Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313642012> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4313642012 endingPage "S25" @default.
- W4313642012 startingPage "S25" @default.
- W4313642012 abstract "Objective To present a case of a patient with recurrent VZV myelitis successfully treated with Intravenous Immunoglobulin (IVIG). Background VZV myelitis is a rare complication of VZV reactivation that tends to be monophasic. There is no solid evidence for a particular treatment regimen for VZV myelitis. No prior reports or studies have looked at using intravenous immunoglobulin for this condition, particularly for refractory cases. Design/Methods 75 year old female with history of hypertension presented with paresthesia on lateral side of right lower extremity, followed by vesicular rash T2 dermatomal distribution. Over a period of 2 weeks patient started experiencing bilateral lower extremity weakness R>L. CNS imaging revealed C3-C6 enhancing lesion and T2 hyperintense lesion. VZV confirmed by skin biopsy. Lumbar puncture (LP) was remarkable only for mildly elevated protein (67 mg/dL), although this LP was 4 weeks after initial symptoms. Patient was treated initially with 5 days of 1 g IV Solumedrol and valacyclovir 1 g TID with improvement of weakness and rash. However, over the next two years, the patient continued to get occasional vesicles with a flare of her myelitis shortly after valacyclovir down-titration trial. She was started on monthly IVIG (1 g/kg IVIG over 2 days) given her refractory and recurrent myelitis. Since starting monthly IVIG, the patient has not had any more zoster outbreaks or further episodes of myelitis. She has gradually improved her balance and gait as well. Results N/A. Conclusions We present an unusual case of recurrent VZV myelitis successfully treated with monthly IVIG. The successful treatment of this patient with IVIG should prompt consideration for its use in similar cases of recurrent VZV myelitis and may provide insight for future studies on how to treat VZV-related diseases. Rapid initiation of this treatment when the condition is recognized early could significantly improve outcomes and patients' quality of life." @default.
- W4313642012 created "2023-01-07" @default.
- W4313642012 creator A5006213158 @default.
- W4313642012 creator A5051899225 @default.
- W4313642012 creator A5090244972 @default.
- W4313642012 date "2022-12-05" @default.
- W4313642012 modified "2023-09-25" @default.
- W4313642012 title "Resolution of Recurrent VZV Myelitis With the Use of Intravenous (IV) Immunoglobulin (IG)" @default.
- W4313642012 doi "https://doi.org/10.1212/01.wnl.0000903212.89120.b9" @default.
- W4313642012 hasPublicationYear "2022" @default.
- W4313642012 type Work @default.
- W4313642012 citedByCount "0" @default.
- W4313642012 crossrefType "journal-article" @default.
- W4313642012 hasAuthorship W4313642012A5006213158 @default.
- W4313642012 hasAuthorship W4313642012A5051899225 @default.
- W4313642012 hasAuthorship W4313642012A5090244972 @default.
- W4313642012 hasConcept C118552586 @default.
- W4313642012 hasConcept C121332964 @default.
- W4313642012 hasConcept C141071460 @default.
- W4313642012 hasConcept C142424586 @default.
- W4313642012 hasConcept C159654299 @default.
- W4313642012 hasConcept C203014093 @default.
- W4313642012 hasConcept C2777704947 @default.
- W4313642012 hasConcept C2778570526 @default.
- W4313642012 hasConcept C2780653079 @default.
- W4313642012 hasConcept C2780775167 @default.
- W4313642012 hasConcept C2781156865 @default.
- W4313642012 hasConcept C2909916134 @default.
- W4313642012 hasConcept C71924100 @default.
- W4313642012 hasConcept C87355193 @default.
- W4313642012 hasConceptScore W4313642012C118552586 @default.
- W4313642012 hasConceptScore W4313642012C121332964 @default.
- W4313642012 hasConceptScore W4313642012C141071460 @default.
- W4313642012 hasConceptScore W4313642012C142424586 @default.
- W4313642012 hasConceptScore W4313642012C159654299 @default.
- W4313642012 hasConceptScore W4313642012C203014093 @default.
- W4313642012 hasConceptScore W4313642012C2777704947 @default.
- W4313642012 hasConceptScore W4313642012C2778570526 @default.
- W4313642012 hasConceptScore W4313642012C2780653079 @default.
- W4313642012 hasConceptScore W4313642012C2780775167 @default.
- W4313642012 hasConceptScore W4313642012C2781156865 @default.
- W4313642012 hasConceptScore W4313642012C2909916134 @default.
- W4313642012 hasConceptScore W4313642012C71924100 @default.
- W4313642012 hasConceptScore W4313642012C87355193 @default.
- W4313642012 hasIssue "23" @default.
- W4313642012 hasLocation W43136420121 @default.
- W4313642012 hasOpenAccess W4313642012 @default.
- W4313642012 hasPrimaryLocation W43136420121 @default.
- W4313642012 hasRelatedWork W2003938723 @default.
- W4313642012 hasRelatedWork W2046165480 @default.
- W4313642012 hasRelatedWork W2047967234 @default.
- W4313642012 hasRelatedWork W2143803333 @default.
- W4313642012 hasRelatedWork W2202764191 @default.
- W4313642012 hasRelatedWork W2351796763 @default.
- W4313642012 hasRelatedWork W2439875401 @default.
- W4313642012 hasRelatedWork W3126033291 @default.
- W4313642012 hasRelatedWork W3205263869 @default.
- W4313642012 hasRelatedWork W4313642012 @default.
- W4313642012 hasVolume "99" @default.
- W4313642012 isParatext "false" @default.
- W4313642012 isRetracted "false" @default.
- W4313642012 workType "article" @default.